IRS-2 is highly expressed in invasive breast tumors, whereas IRS-1 is predominantly expressed in localized tumors [89], and rescue of IRS-2, but not IRS-1, expression in IRS1/2 double null breast tumor cells restores invasive potential [124]. This evidence concerns the gene IRS1 and breast neoplasm.